CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. - FORM 10-Q - EX-32.1 - EXHIBIT 32.1 SECTION 906 CERTIFICATION - November 12, 2014

Attached files

file filename
EX-10.3 - EXHIBIT 10.3 AMENDMENT TO MARCH 5, 2012 NOTE - CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.f10q093014_ex10z3.htm
EX-10.1 - EXHIBIT 10.1 PROMISSORY NOTE - CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.f10q093014_ex10z1.htm
EX-10.5 - EXHIBIT 10.5 AMENDMENT TO JULY 16, 2012 NOTE - CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.f10q093014_ex10z5.htm
EX-10.4 - EXHIBIT 10.4 AMENDMENT TO MAY 2, 2012 NOTE - CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.f10q093014_ex10z4.htm
EX-31.1 - EXHIBIT 31.1 SECTION 302 CERTIFICATION - CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.f10q093014_ex31z1.htm
EX-10.6 - EXHIBIT 10.6 AMENDMENT TO AUG. 7, 2012 NOTE - CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.f10q093014_ex10z6.htm
EX-10.7 - EXHIBIT 10.7 AMENDMENT TO NOV. 1, 2012 NOTE - CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.f10q093014_ex10z7.htm
EX-10.2 - EXHIBIT 10.2 AMENDMENT TO FEB. 8, 2012 NOTE - CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.f10q093014_ex10z2.htm
EXCEL - IDEA: XBRL DOCUMENT - CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.Financial_Report.xls
10-Q - FORM 10-Q QUARTERLY REPORT - CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.f10q093014_10q.htm

EXHIBIT 32.1


CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350


AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection with the quarterly report of  Jolley Marketing, Inc. (the “Company”) on Form 10-Q for the period ended September 30, 2014, as filed with the Securities and Exchange Commission (the “Report”), the undersigned principal executive and financial officer of the Company, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:


(1)

the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and


(2)

the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


Date: November 12, 2014



/s/ Steven L. White

Steven L. White, President

(Principal Executive Officer and Principal Financial Officer)



CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. Reports